tetraiodothyroacetic acid has been researched along with Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
| Mousa, SA; Rajabi, M; Yalcin, M | 1 |
| Davis, PJ; Glinsky, GV; Godugu, K; Lin, HY; Mousa, SA | 1 |
| Müller, AM; Nelson, PJ; Schmohl, KA; Spitzweg, C | 1 |
| Davis, PJ; Godugu, K; Mousa, SA; Sudha, T | 1 |
| Davis, PJ; Lin, HY; Mousa, SA | 1 |
| Nelson, PJ; Schmohl, KA; Spitzweg, C | 1 |
| Cui, H; Fu, R; Hu, M; Li, C; Li, M; Li, X; Li, Z; Lu, L; Luo, M; Sheng, F; Shi, S; Wu, G; Xiang, M; Xu, J; Zhang, Q; Zhou, M | 1 |
| Davis, FB; Davis, PJ; Lin, HY; Luidens, MK; Mousa, SA | 1 |
| Choi, Y; Han, SE; Kim, CW; Kim, J; Kim, K; Kim, S; Kim, YB; Kwon, IC; Lee, S; Oh, YK; Shim, G | 1 |
| Chu, F; Davis, FB; Davis, PJ; Mousa, SA; Rebbaa, A | 1 |
4 review(s) available for tetraiodothyroacetic acid and Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
Thyroid Hormone Effects on Mesenchymal Stem Cell Biology in the Tumour Microenvironment.
Topics: Animals; Humans; Integrin alphaVbeta3; Mesenchymal Stem Cells; Neoplasms; Neovascularization, Pathologic; Thyroid Hormones; Thyroxine | 2020 |
Tetrac as an anti-angiogenic agent in cancer.
Topics: Angiogenesis Inhibitors; Animals; Humans; Mesenchymal Stem Cells; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Thyroxine | 2019 |
Membrane receptor for thyroid hormone: physiologic and pharmacologic implications.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Proliferation; Humans; Integrin alphaVbeta3; Nanoparticles; Neoplasms; Signal Transduction; Thyroxine; Triiodothyronine | 2011 |
7 other study(ies) available for tetraiodothyroacetic acid and Neoplasms
| Article | Year |
|---|---|
Synthesis of new analogs of tetraiodothyroacetic acid (tetrac) as novel angiogenesis inhibitors for treatment of cancer.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Inbred C57BL; Molecular Structure; Neoplasms; Neoplasms, Experimental; Neovascularization, Pathologic; Structure-Activity Relationship; Thyroxine | 2018 |
Topics: Heterografts; Humans; Integrin alphaVbeta3; Neoplasms; Phagocytosis; Thyroid Hormones; Thyroxine | 2022 |
Nano Diaminopropane tetrac and integrin αvβ3 expression in different cancer types: Anti-cancer efficacy and Safety.
Topics: Animals; Antineoplastic Agents; Female; Gene Expression Regulation, Neoplastic; Humans; Integrin alphaVbeta3; Male; Mice, Nude; Nanoparticles; Neoplasms; Polylactic Acid-Polyglycolic Acid Copolymer; Thyroxine; Treatment Outcome | 2021 |
Tetraiodothyroacetic acid (tetrac), integrin αvβ3 and disabling of immune checkpoint defense.
Topics: B7-H1 Antigen; CTLA-4 Antigen; Humans; Integrin alphaVbeta3; Neoplasms; Thyroxine | 2018 |
Synergistic active targeting of dually integrin αvβ3/CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Docetaxel; Drug Liberation; Female; Humans; Hyaluronan Receptors; Hyaluronic Acid; Integrin alphaVbeta3; MCF-7 Cells; Mice, Inbred C57BL; Nanoparticles; Neoplasms; Taxoids; Thyroxine; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |
Tetraiodothyroacetic acid-tagged liposomes for enhanced delivery of anticancer drug to tumor tissue via integrin receptor.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Delivery Systems; Humans; Integrin alphaVbeta3; Liposomes; Mice; Mice, Nude; Neoplasms; Phospholipid Ethers; Thyroxine | 2012 |
Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent.
Topics: Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Humans; Hydroxamic Acids; Mice; Mice, Nude; Neoplasms; Thyroid Hormones; Thyroxine; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2008 |